Editas Medicine· @editasmed · X·· 2026-05-19AI 评分15
AI 导读
很高兴上周参加了 #ASGCT2026 和 #TIDESUSA，我们在会上分享了领先的体内开发候选药物 EDIT-401 的新临床前数据。感谢每一位与 Editas 团队交流的朋友！ #invivo #cardiovasculardisease #biotech
正文
It was a pleasure to participate in #ASGCT2026 and #TIDESUSA last week, where we were excited to share new preclinical data for our lead in vivo development candidate, EDIT-401. Thank you to everyone who spent time with the Editas team!
#invivo #cardiovasculardisease #biotech
来源：Editas Medicine · x.com